News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Sanofi-Aventis (France) Pulls Obesity Drug Application in U.S.
June 29, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LONDON (Reuters) - Sanofi-Aventis said on Friday it was withdrawing its application to sell obesity drug rimonabant -- its biggest new drug hope -- in the United States.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
Europe
Sanofi
MORE ON THIS TOPIC
Drug pricing
9 midsize drugmakers climb aboard Trump’s MFN train
September 1, 2026
·
2 min read
·
Tristan Manalac
Approvals
Takeda, Protagonist score broad FDA nod in rare blood cancer, setting up $2B opportunity
August 31, 2026
·
2 min read
·
Tristan Manalac
FDA
Lilly joins Novo in cardiovascular space after FDA nod for GLP-1/GIP agonist Mounjaro
August 28, 2026
·
2 min read
·
Heather McKenzie
Insights
Fragile X at a turning point: Breaking through the clinical bottleneck
August 27, 2026
·
1 min read
·
Jennifer C. Smith-Parker
